GENPREX

At Genprex, we are dedicated to transforming the lives of patients battling cancer and diabetes through pioneering gene therapies. Our innovative approaches focus on reintroducing tumor suppressor genes to combat cancer and stabilizing glucose levels in diabetes. With multiple FDA Fast Track Designations and promising clinical trial results, Genprex is at the forefront of medical advancements, striving to bring hope and improved outcomes to patients worldwide... Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Our technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. We work with world-class institutions and collaborators to develop drug candidates to further our pipeline of gene therapies in order to provide novel treatment approaches.

Also known as: Genprex, Inc.

Primary location: Austin United States